The Retinal Biologics Market is expected to hold a value of about USD 34,891.44 Million by 2028 and is projected to register a CAGR of 11% from 2022 to 2028. Retinal biologics are bioengineered molecules used to treat a variety of retinal disorders. These biologics are usually implanted into the eye to treat chronic retinal […]
